Veradigm to explore strategic alternatives and reaffirms 2024 guidance

Chicago--(business wire)-- #healthit--veradigm inc. (otcmkts: mdrx, the "company”), a leading provider of healthcare data and technology solutions, today announced that it has initiated a process to explore strategic alternatives to maximize shareholder value. as part of the evaluation process, veradigm will explore potential strategic alternatives that may include, but are not limited to, a sale, merger, strategic business combination or other transaction. the company cannot assure that its exploration wi.
MDRX Ratings Summary
MDRX Quant Ranking